Literature DB >> 8453675

Do the CD45RO+CD8+ intestinal intraepithelial T lymphocytes have the characteristics of memory cells?

E C Ebert1.   

Abstract

Human intraepithelial lymphocytes (IEL) are predominantly CD45RO+ (memory) CD8+ T lymphocytes located between intestinal epithelial cells. This study determines whether IEL share other characteristics with circulating CD45RO+ lymphocytes. Memory cells are large and have an upregulated expression of adhesion molecules. In contrast, the majority of IEL are the same size as peripheral blood (PB) T cells. In addition, IEL do not have an increased density of adhesion molecules, although a larger percentage express CD54 and CD58 compared to PBL. Allo-CTL activity, demonstrated by CD45RO+ PBL, could not be shown using either IEL or lamina propria lymphocytes (LPL) after a 5-day culture with alloantigen. However, after a 2.5-week culture with allogeneic PBL and interleukin-2 (IL-2), both IEL and LPL were capable of this cytotoxic function. The addition of IL-4 or IL-6 did not alter CTL activity by mucosal lymphocytes. Alloantigen-stimulated IEL, LPL, and PB CD8+ T cell lines were propagated for up to 16 weeks. All lines demonstrated alloantigen-specific proliferation. The PB CD8+ T lymphocytes maintained their phenotype and allo-CTL activity. In contrast, the CD4+ subset in the IEL and LPL became the predominant lymphocyte type and demonstrated potent lytic activity that was not alloantigen specific. This study shows that (1) IEL do not have increased density of adhesion molecules, (2) mucosal lymphocytes demonstrate allo-CTL activity, (3) CD8+ T cells in the mucosa cannot be perpetuated long-term by alloantigen and IL-2, and (4) mucosal CD4+ T cell lines demonstrate marked alloantigen-nonspecific cytotoxicity. The only characteristic shared by IEL and circulating memory cells is allo-CTL activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453675     DOI: 10.1006/cimm.1993.1073

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; S D'Alò; R Parroni; D Millimaggi; M G Cifone; G R Corazza
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.

Authors:  E C Ebert; V Mehta; K M Das
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

3.  Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia.

Authors:  Gilles Gargala; Stéphane Lecleire; Arnaud François; Serge Jacquot; Pierre Déchelotte; Jean-Jacques Ballet; Loic Favennec; Philippe Ducrotté
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

4.  Integrin alpha1beta1 (VLA-1) mediates adhesion of activated intraepithelial lymphocytes to collagen.

Authors:  A I Roberts; R E Brolin; E C Ebert
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

5.  Inhibitory effects of transforming growth factor-beta (TGF-beta) on certain functions of intraepithelial lymphocytes.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 6.  Immunopathology of gluten-sensitive enteropathy.

Authors:  H Scott; E Nilsen; L M Sollid; K E Lundin; J Rugtveit; O Molberg; E Thorsby; P Brandtzaeg
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Functional expression of Fas and Fas ligand on human intestinal intraepithelial lymphocytes.

Authors:  Y Morimoto; A Hizuta; E X Ding; T Ishii; T Hongo; T Fujiwara; H Iwagaki; N Tanaka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

8.  Spontaneous cytotoxicity of intestinal intraepithelial lymphocytes: clues to the mechanism.

Authors:  A I Roberts; S M O'Connell; L Biancone; R E Brolin; E C Ebert
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.